iqvia report line revenu face fx relat headwind drive
slight haircut revenu guidanc howev cost contain drove margin upsid
beat rais profit metric compani invest heavili futur
growth opportun continu buy back share reiter neutral
rais pt prior
go salesforc com expand relationship
salesforc becom technolog backbon orchestr
custom engag oce orchestr clinic trial oct sinc launch
oce dec deal includ competit displac
roch origin chosen competitor platform switch oct
new expans salesforc partnership design provid technolog
make clinic trial effici power salesforc healthcloud today
oct offer point solut drug develop includ pilot virtual trial
complianc project timelin call late launch fulli integr clinic
trial suit point includ electron data captur edc
number revenu line estim despit fx
relat headwind ta revenu grew y/i organ
basi revenu increas y/i organ due
earli anniversari segment fx headwind also drove flat
sequenti ftm visibl conctract backlog despit contract backlog
growth quarter csm increas y/i adj ebitda
beat estim exceed guidanc rang driven cost contain
initi strong oper perform factor combin
share repurchas drove ep beat expect
compani lower revenu guidanc account fx headwind rais
midpoint ep guidanc nickel vs pjc consensu
compani shed light continu fx headwind revenu
expect impact top line impact profit next year
valuat transit methodolog price-to-earnings multipl ev/ebitda
adequ factor accret natur share repurchas program
new price target base peer median ep estim
ev/ebitda
chang pharma industri impact spend drug research revers
current increas outsourc trend pharma industri averag leverag
balanc sheet impact opportun
iqvia largest cro industri expertis across major therapeut
oper countri
price close octob
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
sale
compani document piper jaffray co
page
revenu
revenu reimburs expens
consolid incom oper
loss extinguish debt
sale busi
incom tax
tax incom
equiti earn unconsolid affili
loss incom non-control interest
revenu
current disclosur inform compani locat
